Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?
Quach S, Holzgreve A, von Baumgarten L, Niyazi M, Unterrainer M, Thon N, Stöcklein S, Bartenstein P, Tonn J-C, Albert NL (2022)
European Journal of Nuclear Medicine and Molecular Imaging 49(12): 4282-4283.
Zeitschriftenaufsatz
| Veröffentlicht | Englisch
Download
s00259-022-05844-3.pdf
531.76 KB
Autor*in
Quach, StefanieUniBi 
;
Holzgreve, Adrien;
von Baumgarten, Louisa;
Niyazi, Maximilian;
Unterrainer, Marcus;
Thon, Niklas;
Stöcklein, Sophia;
Bartenstein, Peter;
Tonn, Jörg-Christian;
Albert, Nathalie L.
;
Holzgreve, Adrien;
von Baumgarten, Louisa;
Niyazi, Maximilian;
Unterrainer, Marcus;
Thon, Niklas;
Stöcklein, Sophia;
Bartenstein, Peter;
Tonn, Jörg-Christian;
Albert, Nathalie L.Erscheinungsjahr
2022
Zeitschriftentitel
European Journal of Nuclear Medicine and Molecular Imaging
Band
49
Ausgabe
12
Seite(n)
4282-4283
Urheberrecht / Lizenzen
ISSN
1619-7070
eISSN
1619-7089
Page URI
https://pub.uni-bielefeld.de/record/2988835
Zitieren
Quach S, Holzgreve A, von Baumgarten L, et al. Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation? European Journal of Nuclear Medicine and Molecular Imaging. 2022;49(12):4282-4283.
Quach, S., Holzgreve, A., von Baumgarten, L., Niyazi, M., Unterrainer, M., Thon, N., Stöcklein, S., et al. (2022). Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation? European Journal of Nuclear Medicine and Molecular Imaging, 49(12), 4282-4283. https://doi.org/10.1007/s00259-022-05844-3
Quach, Stefanie, Holzgreve, Adrien, von Baumgarten, Louisa, Niyazi, Maximilian, Unterrainer, Marcus, Thon, Niklas, Stöcklein, Sophia, Bartenstein, Peter, Tonn, Jörg-Christian, and Albert, Nathalie L. 2022. “Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?”. European Journal of Nuclear Medicine and Molecular Imaging 49 (12): 4282-4283.
Quach, S., Holzgreve, A., von Baumgarten, L., Niyazi, M., Unterrainer, M., Thon, N., Stöcklein, S., Bartenstein, P., Tonn, J. - C., and Albert, N. L. (2022). Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation? European Journal of Nuclear Medicine and Molecular Imaging 49, 4282-4283.
Quach, S., et al., 2022. Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation? European Journal of Nuclear Medicine and Molecular Imaging, 49(12), p 4282-4283.
S. Quach, et al., “Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?”, European Journal of Nuclear Medicine and Molecular Imaging, vol. 49, 2022, pp. 4282-4283.
Quach, S., Holzgreve, A., von Baumgarten, L., Niyazi, M., Unterrainer, M., Thon, N., Stöcklein, S., Bartenstein, P., Tonn, J.-C., Albert, N.L.: Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation? European Journal of Nuclear Medicine and Molecular Imaging. 49, 4282-4283 (2022).
Quach, Stefanie, Holzgreve, Adrien, von Baumgarten, Louisa, Niyazi, Maximilian, Unterrainer, Marcus, Thon, Niklas, Stöcklein, Sophia, Bartenstein, Peter, Tonn, Jörg-Christian, and Albert, Nathalie L. “Increased TSPO PET signal after radiochemotherapy in IDH-wildtype glioma—indicator for treatment-induced immune activation?”. European Journal of Nuclear Medicine and Molecular Imaging 49.12 (2022): 4282-4283.
Alle Dateien verfügbar unter der/den folgenden Lizenz(en):
Creative Commons Namensnennung 4.0 International Public License (CC-BY 4.0):
Volltext(e)
Name
s00259-022-05844-3.pdf
531.76 KB
Access Level
Open Access
Zuletzt Hochgeladen
2024-04-26T09:25:15Z
MD5 Prüfsumme
5c7a0c40ad556f14bb5113c7285299a8
Google Scholar